PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF TOPOTECAN TO VERIFY EFFLUX TRANSPORTER IN VITRO IN VIVO EXTRAPOLATION.

被引：0
|
作者：
Ning, M. [1 ]
Fang, Z. [2 ]
Hoeckels-Messemer, J. [2 ]
Riedmaier, A. Emami [1 ]
Bow, D. A. [1 ]
机构：
[1] Abbvie Inc, N Chicago, IL USA
[2] Abbvie Inc, Ludwigshafen, Germany
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-081
引用
收藏
页码：S64 / S65
页数：2
相关论文
共 50 条
  • [41] PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR PANTOPRAZOLE IN CHILDREN WITH OBESITY
    Kyler, K.
    Shakhnovich, V.
    Selvarangan, R.
    Sasidharan, A.
    Chan, S.
    Artz, N.
    Williams, V.
    Friesen, C.
    Pearce, R.
    Gaedigk, A.
    Leeder, J.
    Galetin, A.
    Johnson, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S106 - S107
  • [42] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR THE INHIBITION OF ACETYLCHOLINESTERASE BY ORGANOPHOSPHATE ESTERS
    GEARHART, JM
    JEPSON, GW
    CLEWELL, HJ
    ANDERSEN, ME
    CONOLLY, RB
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 : 51 - 60
  • [43] Physiologically-based pharmacokinetic model of in vitro porcine ear skin permeation for drug delivery research
    Krumpholz, Laura
    Polak, Sebastian
    Wisniowska, Barbara
    JOURNAL OF APPLIED TOXICOLOGY, 2024, 44 (12) : 1936 - 1948
  • [44] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR ABSORPTION OF ORAL PARACETAMOL IN MAN
    CLEMENTS, JA
    NIMMO, WS
    HEADING, RC
    PRESCOTT, LF
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 : P60 - P60
  • [45] Physiologically-based pharmacokinetic model for 2,4-dinitrophenol
    Meyer, Lyndsey F.
    Rajadhyaksha, Pooja M.
    Shah, Dhaval K.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2022, 49 (03) : 325 - 336
  • [46] Physiologically Based Pharmacokinetic (PBPK) Modelling for In Vitro-In Vivo Extrapolation: Emphasis on the Use of Dissolution Data
    Ghate, Vivek M.
    Chaudhari, Pinal
    Lewis, Shaila A.
    DISSOLUTION TECHNOLOGIES, 2019, 26 (03): : 18 - 27
  • [47] PREDICTION OF ANTICHOLINESTERASE ACTIVITY AND URINARY METABOLITES OF ISOFENPHOS - USE OF A PERCUTANEOUS PHYSIOLOGICALLY-BASED PHARMACOKINETIC PHYSIOLOGICALLY-BASED PHARMACODYNAMIC MODEL
    KNAAK, JB
    ALBAYATI, MA
    RAABE, OG
    BLANCATO, JN
    BIOMARKERS OF HUMAN EXPOSURE TO PESTICIDES, 1994, 542 : 284 - 300
  • [48] Physiologically based pharmacokinetic model for quinocetone in pigs and extrapolation to mequindox
    Zhu, Xudong
    Huang, Lingli
    Xu, Yamei
    Xie, Shuyu
    Pan, Yuanhu
    Chen, Dongmei
    Liu, Zhenli
    Yuan, Zonghui
    FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT, 2017, 34 (02): : 192 - 210
  • [49] A physiologically based pharmacokinetic model for valnemulin in rats and extrapolation to pigs
    Yuan, L. G.
    Luo, X. Y.
    Zhu, L. X.
    Wang, R.
    Liu, Y. H.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2011, 34 (03) : 224 - 231
  • [50] Combining an In Vitro Kinetic Model with a Physiologically-Based Pharmacokinetic Model to Assess the Potential In Vivo Fate of Polyvinyl Pyrrolidone-Vinyl Acetate Copolymers
    Daniel S. Hsieh
    Liang Luo
    Yan Xu
    Joshua D. Engstrom
    Qi Gao
    Pharmaceutical Research, 2018, 35
12345